Vor Biopharma Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 19.53 USD (Oct 30, 2026, 2:45 PM EDT) · Market cap 1.16B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases. The company offers telitacicept, a novel fusion protein for the treatment of generalized myasthenia gravis, systemic lupus erythematosus, and rheumatoid arthritis, as well as Sjögren’s disease and IgA nephrapathy. It has a license agreement with RemeGen Co., Ltd. for the exploitation, development, and commercialization of telitacicpet and related products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.
Details
| Name | Vor Biopharma Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 76 |
| Founded | 2015 |
| Ipo Date | 2021-02-05 |
| Ceo | Jean-Paul Kress |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 18.00 |
| Isin | US9290332074 |
| Cusip | 929033207 |
| Cik | 1817229 |
| Sic | 2836 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Dr. Jean-Paul Kress M.D. | Chairman, President and Chief Executive Officer |
| Sandesh Mahatme L.L.M. | Chief Business Officer and Chief Financial Officer |
| Dr. Robert Ang M.B.A., M.D., MBBS | Strategic Advisor |
| Dr. Siddhartha Mukherjee DPHIL, M.D., Ph.D. | Scientific Founder and Chairman of Scientific Advisory Board |
| Adi Osovsky | General Counsel |
| Carol Lincoln CCP | Head of Human Resources |
| Dallan Murray | Chief Commercial Officer |
| Dr. Navid Z. Khan Ph.D. | Chief Medical Affairs Officer |
| Dr. Jeremy Sokolove M.D. | Chief Medical Officer |
Contact
| Address | 500 Boylston Street, Suite 1350, Boston, Massachusetts 02116, United States |
| Phone | 617 655 6580 |
| Website | https://www.vorbio.com |